Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Diarrhea rates were 23% for Retatrutide versus 21% for Mounjaro
Not recommended for those with a family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
3E) was 3900- and 82-fold lower than exenatide (K i = 0.092 nM) and liraglutide (K i = 4.4 nM), respectively (Table S6)
The unique formulations produced by these facilities are critical for those with certain sensitivities or administration requirements
Serious but rare side effects can occur with either medication: Pancreatitis (inflammation of the pancreas) Thyroid complications Changes in vision Rapid heartbeat Severe allergic reactions Neither medication should be used if you have a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
While these medications offer significant advantages over traditional weight loss methods, individual responses can vary
